TORONTO, Sept. 11, 2018 /CNW/ - Cannvas MedTech Inc.
("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM), a leading business technology
company in the cannabis space, and Blox Labs Inc. ("BLOX" or "the Company") (CSE: BLOX) (Frankfurt: BR1B), a technology
development company focused on creating best-in-class blockchain software, are pleased to announce the signing of a letter of
intent (the "LOI"), to negotiate, in good faith, a data analytics agreement with respect to "CannaBLOX", a
Blockchain-based smart contract supply chain management platform for the legalized Cannabis industry that BLOX is developing in
partnership with Liberty Leaf Holdings Ltd. (CSE: LIB) (OTC: LIBFF) (FSE: HN3P).
Under the terms of the Agreement, the Parties will assess, amongst other endeavors, various synergies that may exist through
the utilization of Cannvas Data's analytical modeling framework and the various data capture opportunities that the CannaBLOX
platform would provide. Cannvas will develop specific parameters within its existing Cannvas Data framework to collect and
analyze transactional and industry data from the CannaBLOX platform, and their strategic industry partners. CannaBLOX would in
turn gain access to a broad industry-level dataset as they rollout their preliminary module during a beta test phase.
Analytics from CannaBLOX will provide Cannvas Data with the additional insights of supply chain management, dissemination of
cannabis products and their volumes within Canada, and various other transactional information
from its seed-to-sale solution. Our mission statement for Cannvas Data is to collect and analyze data from various credible
sources to enhance our ongoing analytical and modeling framework for the cannabis industry. Cannvas Data will continue to
leverage existing partnership databases, site traffic and contextual technology for user engagement purposes to further its
analytical solutions for the global cannabis community. The Parties have agreed to a discovery period whereby the
technological specifications of the integration will be setup by Cannvas Data and will work together towards a definitive
partnership agreement within the next 60 days.
"Performing analytics on a variety of datasets is our bread and butter with Cannvas Data. Infusing our existing data with
data points provided from a seed-to-sale platform further enriches our ability to provide end-to-end customer behavioral
analytics, industry trend analysis, and much more now that we can analyze the 'pre' and 'post' customer journey" said
Shawn Moniz, CEO of Cannvas Medtech. "We are excited to partner with BLOX Labs to explore
how best to analyze our cannabis industry data together".
About Blox Labs
Blox Labs Inc. is a technology development company focused on creating best-in-class software solutions driven by
emerging trends in Blockchain, Smart Contracts and Decentralized Applications. BLOX is helping customers with solutions for
business problems from proofs of concept through execution. The Company is currently piloting blockchain solutions for supply
chain management and improvement as well as other areas. BLOX is actively targeting partnerships and strategic acquisitions of
growth companies.
About Cannvas Data
Cannvas Data is pioneering to be the social and census data of the cannabis industry by leveraging advanced technology,
machine learning algorithms and scientific and medical research data to provide meaningful insights to the global cannabis
community. Operating as part of the Cannvas.Me platform, Cannvas Data analyzes a multitude of data points captured from those
using medical and adult-use cannabis to improve their health and wellness. The platform is LP/REC agnostic which means it is not
biased by the personal drivers of any one company or institution, and it is continuously evolving and adapting to users and
recognizing and learning from changing trends. For more information visit: www.cannvasdata.com
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric
solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business
drivers.
For additional information:
www.cannvasmedtech.com
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy
of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that
describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a
stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature,
they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its
business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings
with Canadian securities regulators, which are posted on www.sedar.com.
SOURCE Cannvas MedTech Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2018/11/c5039.html